Intel Capital and Khosla Ventures Lead $27M Investment in SiPhox® Health to Transform Health Testing
Summary
BURLINGTON, Mass.–(BUSINESS WIRE)–SiPhox Health, the leader in building the next generation of lab-grade home health testing with silicon photonics, raised $27 million in funding including a $10M Seed financing and a $17M Series A round. The Seed funding was led by Khosla Ventures and Y Combinator with participation from Metaplanet, Massachusetts Manufacturing Innovation Initiative, Rsquared, Vituity, Paul Buchheit, Balaji Srinivasan, Bob Lee, and Longevity Tech Fund among others. Intel Capital managing director Srini Ananth will also join SiPhox Health’s board of directors to further accelerate the company’s growth. Access to low-cost, convenient health testing can help prevent and manage these conditions, improving the lives of patients and enabling many healthcare innovations that are bottlenecked by existing testing approaches. In response to this crisis, MIT scientists Diedrik Vermeulen and Michael Dubrovsky had a vision of using silicon photonics, the semiconductor technology that transformed internet connectivity, to put a lab-grade health testing device in every home.